Home > Insider Trading > Filing (0001104659-23-088491)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1657312	Verona Pharma Plc	VRNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408502	W Mark Hahn	3 More London Riverside London X0 SE1 2RE	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Disposition	2023-08-03	117,272	$2.54	15,679,864	No	4	S	Direct
Ordinary Shares	Disposition	2023-08-04	150,000	$2.50	15,529,864	No	4	S	Direct
Ordinary Shares	Disposition	2023-08-07	8,616	$2.47	15,521,248	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
The price reported represents the sale price of the ADSs divided by eight (8).
Consists of (i) 5,911,816 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 738,977 ADSs); and (ii) 9,609,432 Ordinary Shares underlying 1,201,179 ADSs.